Etizolam-2-one is a synthetic research chemical structurally related to Etizolam, a thienodiazepine derivative. However, Etizolam-2-one features a distinct chemical modification at the 2-position of the diazepine ring, giving it a unique pharmacological profile. This alteration is believed to influence its interaction with GABA-A receptors, which are primarily responsible for mediating inhibitory neurotransmission in the central nervous system. Etizolam-2-one is strictly intended for in vitro or analytical chemical research and is not for human or veterinary use.

• Structural Class: Etizolam-2-one is part of the thienotriazolodiazepine family, a subclass known for potent central nervous system activity in related compounds.

• Primary Research Use: It is studied for its potential binding affinity at GABA-A receptor subtypes, helping researchers model anxiolytic and sedative interactions in a controlled lab setting.

• Chemical Characteristics: It possesses a molecular formula of C17H15ClN4OS and a molecular weight of 358.85 g/mol, consistent with highly active triazolobenzodiazepine analogs.

• Differences from Etizolam: While both are structurally similar, the ‘2-one’ modification in Etizolam-2-one may result in altered potency, receptor selectivity, or metabolism, making it a novel candidate for comparative pharmacology studies.

• Legal Status: It is not scheduled in most jurisdictions, although its similarity to Etizolam may invoke analogue laws depending on local regulations.

• Lab-Only Classification: This compound is strictly labeled for research use and must not be used in humans or animals under any circumstances.

The legality of Etizolam-2-one depends on the specific laws of your country or region, particularly those related to analogues of controlled substances. Although it is not listed as a scheduled compound in many areas, some jurisdictions may restrict its import, sale, or use based on its structural relation to controlled drugs like Etizolam.

• United States: Federally, Etizolam-2-one is unscheduled, but individual states may enforce analogue laws that categorize it similarly to Etizolam, especially if intended for human use.

• European Union: Legal status varies by country. Germany, the UK, and Sweden often regulate such substances under psychoactive substance acts or medicine legislation.

• Australia and New Zealand: Typically prohibited under analogue or blanket psychoactive substance bans.

• Canada: May fall under analogue scheduling laws depending on its intended use and interpretation by authorities.

• Asia and Middle East: Regulations can be very strict, especially in countries like Singapore or the UAE, where analogue and import laws are tightly enforced.

• Best Practice: Always consult your country’s chemical import and psychoactive substance laws before placing an order. Documentation of intended use for research can often be helpful.

Etizolam-2-one is reported by researchers to be more potent on a per milligram basis than Etizolam. This difference in potency is significant because it affects dose sensitivity, onset, and duration in laboratory models. This higher activity means researchers must take extra care in measurement and dilution procedures to ensure precision and safety.

• Microgram Activity Range: Many labs report activity occurring in the low microgram range, whereas Etizolam generally acts in the 0.5–1 mg range.

• Greater Affinity for GABA-A Sites: Early studies suggest a potentially stronger or faster binding profile at GABA-A receptor subtypes compared to Etizolam.

• Faster Onset: Etizolam-2-one may initiate activity more quickly in cellular receptor binding models.

• Shorter Duration: It typically exhibits a shorter half-life, potentially between 2–4 hours, making it more suitable for time-sensitive assays.

• Lower Dosage Requirement: Smaller doses mean less material is needed per experiment but also higher risk of cross-contamination without precision tools.

• Enhanced Research Control: Its rapid action and shorter tail allow clearer observation of onset/offset dynamics in behavioral and electrophysiological studies.

Due to its high potency and fine particulate nature, Etizolam-2-one must be handled under strict laboratory safety conditions. Researchers should implement standard chemical safety protocols and ensure the working environment minimizes risk of contamination or unintentional exposure.

• Use Personal Protective Equipment (PPE): Gloves, lab coats, and eye protection are mandatory when handling this compound. Inhalation masks may be necessary in environments with airflow disturbance.

• Work in a Ventilated Area: Always handle the substance under a fume hood or laminar flow bench to avoid accidental inhalation of airborne particles.

• Precision Measurement: Use a microgram-accurate digital scale for all weighing procedures. Even small overdoses can yield unintended results.

• Label Clearly: Store in a properly labeled container with hazard symbols and lab-use-only indications. Never reuse containers without decontamination.

• Avoid Cross-Contamination: Use separate tools and glassware for each research chemical. Clean surfaces and equipment immediately after use.

• Emergency Protocols: Have spill kits, first-aid measures, and MSDS information accessible in case of accidental exposure or ingestion.

Proper storage conditions are critical for preserving the chemical integrity and potency of Etizolam-2-one. Incorrect storage can lead to degradation, contamination, or reduction in effectiveness during testing.

• Cool, Dry Environment: Store in a climate-controlled space away from heat, moisture, and direct sunlight. Ideally, temperatures should not exceed 25°C.

• Refrigeration Optional: Although not mandatory, refrigeration between 2–8°C may help extend the shelf life, especially in humid climates.

• Airtight Container: Keep the compound sealed in a tight, non-reactive container—preferably amber glass with a secure cap to block light and air exposure.

• Humidity Control: Use desiccants or silica gel packs inside the storage area to control moisture, which can degrade the compound over time.

• Avoid Frequent Handling: Opening the container repeatedly may expose the powder to oxygen or humidity. Portion samples ahead of time if necessary.

• Shelf Life Estimates: Under proper conditions, Etizolam-2-one remains stable for 12 to 24 months. Look for color changes or texture shifts as signs of degradation.

Yes, Etizolam-2-one is soluble in several non-aqueous solvents commonly used in research settings. However, it is not water-soluble, and its preparation for solution studies should be handled under strict laboratory protocols to maintain integrity and avoid degradation. Proper dissolution is crucial for ensuring accurate dose delivery during in vitro assays or solution-based chemical studies.

• Solvent Compatibility: Etizolam-2-one dissolves readily in ethanol, dimethyl sulfoxide (DMSO), and polyethylene glycol (PEG). These solvents are standard in receptor binding and neurochemical research.

• Avoid Water Solvents: The compound has poor solubility in water and water-based buffers, which may lead to incomplete dissolution and ineffective experimental outcomes.

• Weigh Before Mixing: Always use a calibrated microbalance to measure solid mass before dilution to avoid inaccuracies in solution concentration.

• Use Sterile Techniques: Ensure that all labware is sterile and solvent-grade to prevent chemical contamination during dissolution.

• Prepare Fresh When Possible: Some solutions may degrade over time; prepare fresh solutions for each experiment when stability data is lacking.

• Use Amber Vials: Store prepared solutions in amber glass vials to prevent light degradation of the active compound.

Understanding the physical traits of Etizolam-2-one helps confirm authenticity and detect contamination or degradation. These characteristics also aid in proper handling, dosing, and formulation for experimental use. Consistency in appearance is one of the first indicators of compound purity.

• Appearance: Etizolam-2-one typically presents as a white to off-white crystalline powder. Slight yellowing may occur with prolonged exposure to air or moisture but should not be extreme.

• Texture: The compound is fine-grained and lightweight, easily dispersible when agitated but prone to becoming airborne—hence requiring cautious handling.

• Odor: It is essentially odorless, which aligns with its classification as a research-grade compound.

• Clumping: In environments with high humidity or improper storage, minor clumping may occur. If observed, this may suggest moisture exposure.

• Light Sensitivity: Over time, exposure to UV or intense light may cause discoloration. Always store in low-light or UV-protected environments.

• Melting Point (Estimated): While exact values are not universally confirmed, most analogues in this class melt in the 150–200°C range—helpful for confirming identity via thermal analysis.

Etizolam-2-one is a highly specialized research chemical primarily used in neuroscientific and pharmacological research. Its unique interaction with GABA-A receptors makes it a promising candidate for modeling sedative, anxiolytic, and receptor-binding effects in a lab setting. It is not intended for medical or recreational use under any circumstances.

• GABAergic Modulation Studies: Its primary use is to explore modulation of the gamma-aminobutyric acid (GABA-A) receptor system, especially in CNS inhibitory pathways.

• Receptor Binding Affinity Research: It serves as a model compound to assess how structural variations affect binding strength, selectivity, and duration of action.

• Structure-Activity Relationship (SAR) Studies: Etizolam-2-one offers valuable insights into how minor molecular changes impact pharmacological activity.

• Sedation Mechanism Analysis: Often used in in vitro models or animal studies (under strict research protocols) to observe acute sedation effects.

• Rapid-Onset Compound Testing: Its short duration and fast onset make it suitable for timed behavioral or receptor activation experiments.

• Preclinical Analogue Comparisons: Researchers use it to compare with Etizolam and other benzodiazepines to understand class-specific behavior.

Etizolam-2-one is not explicitly scheduled under the U.S. federal Controlled Substances Act (CSA). However, this does not guarantee legality, especially if analog laws apply. Researchers must stay informed about the chemical’s legal interpretation in their jurisdiction.

• United States: Federally unscheduled, but may be prosecuted under the Federal Analogue Act if intended for human use.

• State Regulations: Several U.S. states restrict or classify benzodiazepine analogues differently; Etizolam-2-one may fall under similar laws.

• European Union: Varies by country. Germany and the UK may regulate it under psychoactive substance laws or analog legislation.

• Canada: Potentially falls under Schedule IV analogue classifications.

• Asia, Australia, New Zealand: Likely banned or heavily restricted due to broad psychoactive substance prohibitions.

• Lab Use Exception: In many jurisdictions, Etizolam-2-one is legal when clearly used for scientific research, not for human consumption.

Though both Etizolam-2-one and Flubromazolam are research chemicals that interact with GABA-A receptors, they differ significantly in potency, onset, half-life, and safety profile. Understanding these differences is vital for choosing the right compound for specific research applications.

• Structural Differences: Etizolam-2-one is a thienotriazolodiazepine, while Flubromazolam belongs to the triazolobenzodiazepine class. These core structure differences result in varying receptor affinity and selectivity.

• Potency: Flubromazolam is significantly more potent—active at sub-milligram levels—whereas Etizolam-2-one is potent but more manageable in microgram-to-low-milligram ranges.

• Duration of Action: Flubromazolam is long-lasting (often 12–18 hours or more), while Etizolam-2-one has a shorter window of action (2–4 hours).

• Risk of Accumulation: Due to Flubromazolam’s long half-life, there’s a greater risk of compound build-up in repeated studies. Etizolam-2-one, with its short half-life, is often preferred in acute studies where clearance speed matters.

• Solubility Profiles: Both compounds are poorly water-soluble, but Flubromazolam can be even more challenging to dissolve, requiring careful solvent selection.

• Research Focus: Etizolam-2-one is typically used for rapid-onset behavioral or receptor activity studies, while Flubromazolam is explored for prolonged modulation modeling or long-term receptor desensitization.

Mixing Etizolam-2-one with other research chemicals is strongly discouraged unless it is part of a precisely designed and controlled study. Combining active compounds without complete understanding of their interactions can compromise research outcomes, lead to unexpected chemical reactions, or pose safety risks in laboratory environments.

• Risk of Cross-Reactivity: Etizolam-2-one’s mechanism at GABA-A receptors can be influenced by other CNS-active compounds, altering results unpredictably.

• Chemical Stability Concerns: Combining substances in solution or powder form without validated compatibility data may cause degradation or precipitation.

• Loss of Research Clarity: Co-administration or mixed testing reduces the ability to isolate pharmacodynamic or pharmacokinetic variables specific to Etizolam-2-one.

• Increased Handling Hazards: Introducing other compounds—especially those with unknown toxicological profiles—can elevate risk during storage, weighing, or dosing.

• Regulatory Complexity: Mixed samples may draw more scrutiny during transport, import, or regulatory review, as identifying individual components becomes difficult.

• Experimental Controls: If combinations are part of a formal protocol, they must be accompanied by control trials, stability assays, and post-mixture analytical validation.

Yes. At RC Plug, we conduct comprehensive analytical testing on every batch of Etizolam-2-one before it is made available for purchase. Ensuring the chemical identity, purity, and consistency of our research materials is a core part of our quality guarantee.

• HPLC and GC-MS Testing: Each batch undergoes High-Performance Liquid Chromatography (HPLC) and/or Gas Chromatography-Mass Spectrometry (GC-MS) to verify compound purity and identity.

• ≥98% Verified Purity: We guarantee a minimum of 98% chemical purity, with actual batches often exceeding this baseline.

• Batch-Level Reports: Upon request, researchers can access full COA (Certificate of Analysis) documents for the exact batch they receive.

• Solvent and Contaminant Screening: Our lab checks for residual solvents, moisture content, and possible synthesis by-products.

• Third-Party Verification: Independent labs are used to ensure impartial validation and compliance with industry research standards.

• Tamper-Evident Packaging: All verified batches are sealed and labeled with tamper-evident technology to ensure you receive an unaltered product.

No. Etizolam-2-one is a research chemical not intended for human or veterinary use. Its safety, efficacy, metabolism, and toxicity have not been established through clinical trials, making it unsuitable for any form of direct consumption.

• Lack of Clinical Data: No human safety studies exist for Etizolam-2-one, and its pharmacokinetics are largely theoretical or modeled via analogues.

• Toxicological Unknowns: Potential side effects, long-term organ impact, or metabolite formation in humans are not documented or understood.

• Legal Consequences: Using or distributing Etizolam-2-one for human consumption could violate analogue laws, drug safety regulations, or pharmaceutical licensing codes.

• Risk of Overdose: Its high potency, especially in microgram quantities, makes accidental overdose a significant concern without precise laboratory controls.

• Not Approved by Any Health Agency: This compound is not registered or authorized by the FDA, EMA, or any other health authority for medical use.

• RC Plug Disclaimer: We clearly label all products as “not for human consumption” and will refuse service to anyone suspected of misuse.

Shipping times for Etizolam-2-one vary based on destination, shipping method, and customs clearance times. RC Plug ensures efficient, trackable, and discreet delivery, with expedited options available for priority research needs.

• Domestic (U.S./EU): Overnight or 1–2 business day delivery options are available for most metropolitan areas.

• International Delivery: Typical delivery ranges between 3–7 business days depending on location and customs processing.

• Discreet Packaging: All items are shipped in plain, secure parcels with no external reference to chemical contents.

• Tracking Provided: Each order includes a tracking number for real-time shipping updates.

• Customs Support: We assist with documentation and declarations where necessary to prevent delays or seizures.

• Delayed Deliveries: If your order does not arrive within the estimated timeframe, we will offer full support, including reshipment if needed.

If your Etizolam-2-one order is lost in transit, RC Plug offers a customer-first resolution policy to ensure your research remains uninterrupted. We recognize the critical nature of timely chemical delivery and aim to address any issues swiftly and transparently.

• 30-Day Refund or Reshipment Policy: If your package is not delivered within the expected timeframe, you may request either a full refund or a one-time free reshipment.

• Easy Dispute Process: Simply provide your tracking number and any delivery correspondence. Our team will investigate with the courier directly.

• No Additional Charges: Replacements and refunds are processed at no cost to you if the fault lies in the shipping chain or our logistics.

• Priority Handling on Reshipment: In cases of reshipment, your replacement order will be prioritized and shipped via the fastest available service.

• Data Retention: Your information remains private and secure throughout the process; no data is shared externally during claims.

• Fraud Protection: While we protect against lost shipments, we also reserve the right to investigate potential fraudulent claims to ensure fairness.

Authenticity is critical in chemical research, especially with high-potency compounds like Etizolam-2-one. At RC Plug, we prioritize transparency and quality control, ensuring that every order you receive is verified, tamper-proof, and sourced from trusted suppliers. Our rigorous standards eliminate the guesswork from sourcing your research materials.

• Certificate of Analysis (COA): Every batch is lab-tested with documented analysis confirming identity, structure, and ≥98% purity.

• Batch Number Verification: Each package includes a batch number that corresponds to lab results and test reports, ensuring full traceability.

• Tamper-Evident Packaging: We seal our products using industry-grade vacuum and security labels, providing a clear indication of interference.

• Visual and Physical Consistency: Appearance (color, texture) matches detailed specifications listed on the product page and COA.

• Third-Party Lab Testing: Whenever necessary, we use external labs to verify key parameters like purity, structure, and absence of contaminants.

• Customer Feedback & Repeat Orders: A high percentage of return buyers and positive feedback reflect our product reliability and consistency.

Do I need a license to buy Etizolam-2-one?

In most cases, Etizolam-2-one can be purchased for research purposes without a license, particularly when its use is clearly documented and not intended for human consumption. However, certain jurisdictions may impose restrictions based on the compound’s similarity to controlled substances or due to specific chemical control laws.

• Research-Only Access: We sell exclusively to customers who affirm that their intended use is strictly scientific or analytical.

• No Prescription Required: Etizolam-2-one is not a registered pharmaceutical; therefore, no medical prescription is applicable or accepted.

• Country-Specific Policies: Licensing or permits may be required in countries with analogue or psychoactive substance laws—especially in parts of Europe, Asia, and Oceania.

• University or Lab Requirements: Institutional buyers may require documentation or internal clearance before procurement, depending on local ethics protocols.

• Customs Regulations: Some countries may require import licenses even if the substance is not scheduled. Always verify with your national import authority.

• Declaration of Intended Use: While we do not require formal documentation, we reserve the right to deny sales if misuse is suspected.

Yes. Like most research compounds, Etizolam-2-one has a finite shelf life and can degrade over time, especially under poor storage conditions. Maintaining proper environmental controls will extend the life and integrity of the compound, preserving its research value.

• Shelf Life: When stored correctly, Etizolam-2-one typically remains stable for 12 to 24 months.

• Degradation Signs: Discoloration, moisture-induced clumping, or changes in odor or solubility may indicate loss of chemical integrity.

• Optimal Storage Conditions: Store in a cool, dry, dark location—ideally in a refrigerated environment (2–8°C) within an airtight container.

• Avoid Frequent Handling: Each exposure to air or light can hasten degradation. Minimize container openings and reseal tightly after each use.

• Batch-Specific Stability: Stability may vary slightly depending on synthesis method and storage environment, so always refer to COA data when available.

• Use-By Date: While not legally mandated, we recommend noting the date of receipt and aiming to use the compound within 18 months.

Yes, RC Plug takes your privacy and data protection seriously, both during the order process and after fulfillment. Whether you’re a private researcher or institutional buyer, we maintain complete confidentiality across all communications, transactions, and deliveries.

• Discrete Billing and Shipping: Packages are unbranded and contain no references to chemical contents or company names.

• Secure Online Checkout: Our checkout systems use encrypted connections to ensure payment data remains protected and anonymous.

• Anonymous Payment Options: We accept Bitcoin, Zelle, Western Union, and other methods that preserve transaction privacy.

• No Data Sharing: We never sell, rent, or disclose your personal or order data to third parties.

• Internal Privacy Controls: Access to customer data is restricted to essential personnel only and managed through secure protocols.

• Order History Confidentiality: Your purchasing history is never linked to any external system or publicly accessible records.

While both compounds share a similar core structure, researchers often prefer Etizolam-2-one due to its refined potency, shorter duration, and cleaner pharmacological profile. These traits make it a more precise tool for specific types of receptor or behavioral studies, especially when rapid onset and controlled washout periods are desired.

• Shorter Half-Life: Etizolam-2-one is ideal for time-sensitive assays where long-acting effects would interfere with study endpoints.

• Enhanced Onset: Faster onset allows researchers to observe acute receptor responses within a shorter window.

• Improved Modulation Profile: Early receptor binding studies suggest a slightly different subtype affinity, offering insights not available with Etizolam alone.

• Less Accumulation Risk: Reduced systemic persistence reduces risk of compound build-up in multi-phase experiments.

• Structural Novelty: The added ketone group in the 2-position offers unique structure-activity relationship (SAR) data.

• Greater Availability in Some Regions: Etizolam may be restricted in jurisdictions where Etizolam-2-one is not, offering more accessible study conditions.

Researchers often choose Etizolam-2-one over Etizolam for studies that require a more controlled, short-acting compound with potent GABA-A receptor affinity. While both substances belong to the same class, Etizolam-2-one’s structural modification makes it uniquely valuable in certain experimental designs.

• Faster Onset: Etizolam-2-one reaches peak activity more rapidly, allowing researchers to observe early-phase responses with better timing.

• Shorter Duration: The compound clears from the system quickly in comparative receptor models, minimizing residual effects between trials.

• Greater Experimental Precision: Its fast action and quick washout phase make it ideal for tightly timed behavioral or neuropharmacological assays.

• Novel SAR Value: The additional ketone at the 2-position provides new insights into structure-activity relationships within the thienodiazepine class.

• Regulatory Advantage: In some countries, Etizolam is controlled while Etizolam-2-one is unscheduled, expanding research accessibility.

• Lower Sedation Carryover: Unlike Etizolam, which can linger in system models, Etizolam-2-one presents less sedative tailing, improving clarity between experimental phases.